Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new agreement with FUJIFILM Diosynth Biotechnologies to manufacture and supply bulk drug product of Regeneron’s commercial biologic medicines at their Holly Springs, North Carolina, campus. Regeneron, already one of the largest manufacturers of biologics in the world, will nearly double its U.S.…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
